June 2026
The global drug and gene delivery devices market size is projected to hit around USD 1,875.96 million by 2035 from USD 792.67 million in 2025, with a CAGR of 9.00%.
June 2026
The global insulin drugs and delivery devices market size is evaluated at USD 25.53 billion in 2025 and is predicted to hit around USD 52.72 billion by 2035, growing at a CAGR of 7.52%.
July 2026
The next?gen delivery systems for genetic drug market is expanding with lipid nanoparticles, viral vectors, and extracellular vesicles enabling precision gene delivery.
June 2026
The global subcutaneous drug delivery devices market size was valued at USD 36.12 billion in 2025 and is projected to hit around USD 74.66 billion by 2035 with a CAGR of 7.53%.
June 2026
The implantable drug delivery devices market size is valued at USD 13.29 billion in 2025 and is expected to hit around USD 22.01 billion by 2035 with a CAGR of 5.17%.
April 2026
The global intranasal drug delivery devices market size surpassed USD 1868.61 million in 2025 and is projected to hit around USD 4949.45 million by 2035, with a noteworthy CAGR of 10%.
December 2025
The drug delivery devices market size is valued at USD 303.28 billion in 2025 and is expected to hit around USD 533.31 billion by 2035, growing at a CAGR of 5.81% from 2026 to 2035.
April 2026
The contraceptive drugs and devices market size reached USD 33.26 billion in 2025 and is projected to surpass around USD 58.87 billion by 2035, with a notable CAGR of 5.88%.
February 2026
The global epigenetics drugs and diagnostic technologies market size is estimated to hit around USD 79.03 billion by 2035 increasing from USD 20.17 billion in 2025, with a CAGR of 14.63%.
January 2026
The global generic drugs market size is estimated at USD 491.67 billion in 2026 and is projected to reach USD 762.48 billion by 2035 at a 5% CAGR, driven by rising demand for affordable medicines and patent-expired drugs.
July 2025
The inhalation and nasal spray generic drugs market size is projected to hit around USD 54.44 billion by 2034 from USD 23.06 billion in 2024, with a CAGR of 8.97%.
July 2025
The cell and gene therapy infrastructure market is expanding with scalable manufacturing, integrated delivery networks, and advanced clinical site readiness.
June 2026
The global epigenetic drugs market size is anticipated at USD 16.22 billion in 2025 and is predicted to hit around USD 92.57 billion by 2035, growing at a CAGR of 19.03%.
June 2026
The global topical drug delivery market size was valued at USD 136.35 billion in 2025 and is expected to hit around USD 324.67 billion by 2035, growing at a CAGR of 9.06%.
June 2026
The global pulmonary drug delivery systems market size is projected to hit around USD 91.51 billion by 2035 from USD 58.33 billion in 2025, with a CAGR of 4.61%.
June 2026
The global pharmaceutical drug delivery market size was calculated at USD 2.07 trillion in 2025 and is projected to hit around USD 3.32 trillion by 2035 with a CAGR of 4.84%.
June 2026
The general surgery devices market size was valued at USD 16.65 billion in 2025 and is expected to hit around USD 37.14 billion by 2035, growing at a CAGR of 8.35% from 2025 to 2034.
May 2026
The global nanotechnology drug delivery market size was valued at USD 105.95 billion in 2025 and is expected to hit around USD 222.96 billion by 2035, growing at a CAGR of 7.72%.
May 2026
The global gene delivery technologies market size was valued at USD 6.19 billion in 2025 and is expected to hit around USD 25.87 billion by 2035, growing at a CAGR of 15.37%.
May 2026
The global vaccine delivery devices market size was evaluated at USD 8.06 billion in 2025 and is predicted to hit around USD 17.10 billion by 2035, growing at a CAGR of 7.81%.
April 2026
The global nasal drug delivery technology market size is expected to surge around USD 179.41 billion by 2035 from USD 88.85 billion in 2025, growing at a CAGR of 7.28%.
April 2026
The global transdermal drug delivery systems market size was evaluated at USD 78.20 billion in 2025 and is predicted to hit around USD 239.43 billion by 2035, growing at a CAGR of 11.84%.
February 2026
The global gastro-retentive drug delivery systems outsourcing market size is expected to increase from USD 2.04 billion in 2025 to hit around USD 3.86 billion by 2035, growing at a CAGR of 6.58%.
February 2026
The U.S. generic drugs market size was exhibited at USD 146.04 billion in 2025 and is projected to hit around USD 243.70 billion by 2035 with a CAGR of 5.25%.
January 2026
The injectable drug delivery market size was valued at USD 764.6 billion in 2025 and is projected to hit around USD 1,719.57 billion by 2035 with a CAGR of 8.45%.
January 2026
The global allogeneic cell therapy devices market size is projected to hit around USD 4,565.79 million by 2035 from USD 511.30 million in 2025 with a CAGR of 24.48%.
January 2026
The generative AI in drug discovery market size reached USD 260.56 million in 2025 and is estimated to hit around USD 2,724.15 million by 2035, at a CAGR of 26.45%.
December 2025
The global insulin delivery devices market size is calculated at USD 21.13 billion in 2025 and is projected to hit around USD 39.12 billion by 2035 with a CAGR of 6.35%.
December 2025
The global controlled release drug delivery market size is projected to hit around USD 160.09 billion by 2035 from USD 66.80 billion in 2025, with a CAGR of 9.13%.
December 2025
The advanced drug delivery market size is calculated at USD 89.83 billion in 2025 and is projected to hit around USD 371.83 billion by 2035 with a CAGR of 15.26%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com